Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness.

Fight for Sight Logo

18 January 2019
Source: Fight for Sight

Fight for Sight funded research published this week in ‘Clinical Epigenetics’, has identified new genes linked to the development of age-related macular degeneration, the leading cause of blindness in the UK. The research team, led by Dr Louise Porter at the University of Liverpool, have identified genes that may represent new targets for the development of treatments. Currently there is

Read more Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness.

Macular Society to hold Professional Conference in October

25 July 2018
Source: Macular Society

The Macular Society will hold its third Professional Conference in October. Tickets are  now available for the event, ‘Excellence in Patient Support’, which takes place on Tuesday 16 October at Conference Aston, Aston University, Birmingham. The conference is open to all staff working in the eye care sector. It will focus on the latest in macular treatments, NICE guidelines, the

Read more Macular Society to hold Professional Conference in October

Dates for Macular Society UK roadshows announced

26 March 2018
Source: Macular Society

Leading UK sight loss charity the Macular Society has announced the dates for four regional roadshows which will highlight new treatments and research into macular degeneration. The four events, which take place throughout May and June in Cardiff, Newcastle-upon-Tyne, Southampton and Ipswich, will give people with macular degeneration the chance to find out about the latest developments in treating their

Read more Dates for Macular Society UK roadshows announced

Patients with High-Risk Macular Degeneration Show Improvement with High-Dose Statin Treatment

7 March 2016
Source: Harvard Medical school

A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world, and though effective treatments are available for the wet AMD, they are currently

Read more Patients with High-Risk Macular Degeneration Show Improvement with High-Dose Statin Treatment